P. Ancel, F. Goffinet, . Epipage-2-writing, and . Group, Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study, JAMA Pediatr, vol.169, pp.2225-2233, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01258705

K. L. Costeloe, E. M. Hennessy, and S. Haider, Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies), BMJ, vol.345, p.7976, 2012.

D. J. Field, J. S. Dorling, B. N. Manktelow, and E. S. Draper, Survival of extremely premature babies in a geographically defined population: prospective cohort study of 1994-9 compared with 2000-5, BMJ, vol.336, pp.1221-1223, 2008.

B. J. Stoll, N. I. Hansen, and E. F. Bell, Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network, Pediatrics, vol.126, pp.443-456, 2010.

M. M. Bode, D. B. Eugenio, and N. Forsyth, Outcome of extreme prematurity: a prospective comparison of 2 regional cohorts born 20 years apart, Pediatrics, vol.124, pp.866-874, 2009.

M. Chiang, R. Arons, J. Flynn, and J. Starren, Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database, Ophthalmology, pp.1317-1342, 2004.

A. L. Bashinsky, . Retinopathy, and . Prematurity, N C Med J, vol.78, pp.124-128, 2017.

L. Kong, M. Fry, and M. Al-samarraie, An update on progress and the changing epidemiology of causes of childhood blindness worldwide, J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus, vol.16, pp.501-507, 2012.

, Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial, Arch Ophthalmol Chic Ill, vol.121, pp.1684-1694, 1960.

P. Ancel and F. Goffinet, EPIPAGE 2 Writing Group. EPIPAGE 2: a preterm birth cohort in France in 2011, BMC Pediatr, vol.14, p.97, 2014.

T. L. Terry, Fibroblastic Overgrowth of Persistent Tunica Vasculosa Lentis in Infants Born Prematurely: II. Report of Cases-Clinical Aspects, Trans Am Ophthalmol Soc, vol.40, pp.262-284, 1942.

A. Patz, L. E. Hoeck, D. Cruz, and E. , Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations, Am J Ophthalmol, vol.35, pp.1248-1253, 1952.

L. M. Askie, D. J. Henderson-smart, and H. Ko, Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants, Cochrane Database Syst Rev, p.1077, 2009.

R. A. Polin and D. Bateman, Oxygen-saturation targets in preterm infants, N Engl J Med, vol.368, pp.2141-2142, 2013.

, Oxygen saturation and outcomes in preterm infants, N Engl J Med, vol.368, pp.2094-2104, 2013.

W. A. Carlo and N. N. Finer, Target ranges of oxygen saturation in extremely preterm infants, N Engl J Med, vol.362, pp.1959-1969, 2010.

B. A. Darlow, K. Lui, and S. Kusuda, International variations and trends in the treatment for retinopathy of prematurity, Br J Ophthalmol, vol.101, pp.1399-1404, 2017.

M. Hiraoka, T. Watanabe, and T. Kawakami,

, Nippon Ganka Gakkai Zasshi, vol.108, pp.600-605, 2004.

A. Zin and G. A. Gole, Retinopathy of prematurity-incidence today, Clin Perinatol, vol.40, pp.185-200, 2013.

C. Gilbert, J. Rahi, and M. Eckstein, Retinopathy of prematurity in middle-income countries, Lancet Lond Engl, vol.350, pp.12-14, 1997.

B. P. Connolly, E. Ng, and J. A. Mcnamara, A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome, Ophthalmology, vol.109, pp.936-941, 2002.

. Anon, Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group, Arch Ophthalmol Chic Ill, vol.1960, pp.471-479, 1988.

E. C. Broxterman and D. A. Hug, Retinopathy of Prematurity: A Review of Current Screening Guidelines and Treatment Options, Mo Med, vol.113, pp.187-190, 2016.

A. Hellström, L. Smith, and O. Dammann, Retinopathy of prematurity, Lancet Lond Engl, vol.382, pp.1445-1457, 2013.

H. Offret, Embryologie de l'oeil et de ses annexes

. Anon, Archipel -Catalogue Informatisé des BU de Toulouse, 2017.

C. Löfqvist, E. Engström, and J. Sigurdsson, Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit, Pediatrics, vol.117, pp.1930-1938, 2006.

S. E. Brooks, X. Gu, and S. Samuel, Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice, Invest Ophthalmol Vis Sci, vol.42, pp.222-228, 2001.

M. Leduc, E. Kermorvant-duchemin, and D. Checchin, Hypercapnia-and transArachidonic Acid-Induced Retinal Microvascular Degeneration: Implications in the Genesis of Retinopathy of Prematurity, Semin Perinatol, vol.30, pp.129-138, 2006.

M. E. Hartnett, Pathophysiology and mechanisms of severe retinopathy of prematurity, Ophthalmology, vol.122, pp.200-210, 2015.

L. Smith, Pathogenesis of retinopathy of prematurity, Semin Neonatol SN, vol.8, pp.469-473, 2003.

L. C. Chow, K. W. Wright, and A. Sola, CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?, Pediatrics, vol.111, pp.339-345, 2003.

E. A. Pierce, E. D. Foley, and L. E. Smith, Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity, Arch Ophthalmol Chic Ill, vol.114, pp.1219-1228, 19601996.

P. A. Campochiaro, Retinal and choroidal neovascularization, J Cell Physiol, vol.184, pp.301-310, 2000.

P. Sapieha, M. Sirinyan, and D. Hamel, The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis, Nat Med, vol.14, pp.1067-1076, 2008.

E. Kermorvant-duchemin, F. Sennlaub, F. Behar-cohen, and S. Chemtob, EXPRESS Group. Incidence of and risk factors for neonatal morbidity after active perinatal care: extremely preterm infants study in Sweden (EXPRESS), Acta Paediatr Oslo Nor, vol.18, pp.978-992, 1992.

L. M. Pierce, E. L. Raab, and I. R. Holzman, Importance of birth weight as a risk factor for severe retinopathy of prematurity when gestational age is 30 or more weeks, Am J Ophthalmol, vol.157, pp.1227-1230, 2014.

P. Lundgren, A. Kistner, and E. M. Andersson, Low birth weight is a risk factor for severe retinopathy of prematurity depending on gestational age, PloS One, vol.9, p.109460, 2014.

A. Hellström, E. Engström, and A. Hård, Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth, Pediatrics, vol.112, pp.1016-1020, 2003.

E. A. Palmer, J. T. Flynn, and R. J. Hardy, Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group, Ophthalmology, vol.98, pp.1628-1640, 1991.

X. Qiu, A. Lodha, and P. S. Shah, Neonatal outcomes of small for gestational age preterm infants in Canada, Am J Perinatol, vol.29, pp.87-94, 2012.

A. Larnkjaer, C. Mølgaard, and K. F. Michaelsen, Early nutrition impact on the insulin-like growth factor axis and later health consequences, Curr Opin Clin Nutr Metab Care, vol.15, pp.285-292, 2012.

N. Koçak, L. Niyaz, and N. Ariturk, Prediction of severe retinopathy of prematurity using the screening algorithm WINROP in preterm infants, J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus, vol.20, pp.486-489, 2016.

E. Kermorvant-duchemin, A. C. Pinel, and S. Lavalette, Neonatal Hyperglycemia Inhibits Angiogenesis and Induces Inflammation and Neuronal Degeneration in the Retina, PLOS ONE, vol.8, p.79545, 2013.

J. W. Kaempf, A. J. Kaempf, and Y. Wu, insulin and slower growth velocity may increase the risk of retinopathy of prematurity, J Perinatol Off J Calif Perinat Assoc, vol.31, pp.251-257, 2011.

L. Mohsen, M. Abou-alam, and M. El-dib, A prospective study on hyperglycemia and retinopathy of prematurity, J Perinatol Off J Calif Perinat Assoc, vol.34, pp.453-457, 2014.

J. H. Lee, C. P. Hornik, and D. Testoni, Insulin, Hyperglycemia, and Severe Retinopathy of Prematurity in Extremely Low-Birth-Weight Infants, Am J Perinatol, vol.33, pp.393-400, 2016.

C. Slidsborg, L. B. Jensen, and S. C. Rasmussen, Early postnatal hyperglycaemia is a risk factor for treatment-demanding retinopathy of prematurity, Br J Ophthalmol, vol.102, pp.14-18, 2018.

G. V. Nicolaeva, E. I. Sidorenko, and A. L. Iosifovna, Influence of the blood glucose level on the development of retinopathy of prematurity in extremely premature children, Arq Bras Oftalmol, vol.78, pp.232-235, 2015.

S. Au, S. Tang, and S. Rong, Association between hyperglycemia and retinopathy of prematurity: a systemic review and meta-analysis, Sci Rep, vol.5, p.9091, 2015.

J. Ma and H. Ye, Effects of permissive hypercapnia on pulmonary and neurodevelopmental sequelae in extremely low birth weight infants: a meta-analysis, SpringerPlus, vol.5, p.764, 2016.

P. G. Woodgate and M. W. Davies, Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants, Cochrane Database Syst Rev, p.2061, 2001.

J. Kamper, F. Jørgensen, N. Jonsbo, and F. , The Danish national study in infants with extremely low gestational age and birthweight (the ETFOL study): respiratory morbidity and outcome, Acta Paediatr Oslo Nor, vol.93, pp.225-232, 1992.

D. Lockington, T. E. Lavy, and J. R. Mackinnon, Is retinopathy of prematurity seasonal? Implications for screening and treatment, Eye, vol.25, p.954, 2011.

M. B. Yang, S. Rao, D. R. Copenhagen, and R. A. Lang, Length of day during early gestation as a predictor of risk for severe retinopathy of prematurity, Ophthalmology, vol.120, pp.2706-2713, 2013.

E. U. Kabata?, N. F. Dinlen, and A. Zenciro?lu, Relationship between serum 25-hydroxy vitamin D levels and retinopathy of prematurity, Scott Med J, vol.62, pp.129-135, 2017.

K. W. Tolsma, E. N. Allred, and M. L. Chen, Neonatal bacteremia and retinopathy of prematurity: the ELGAN, Arch oph, vol.129, issue.12, pp.1555-63, 2011.

P. Lundgren, L. Lundberg, and G. Hellgren, Aggressive Posterior Retinopathy of Prematurity Is Associated with Multiple Infectious Episodes and Thrombocytopenia, Neonatology, vol.111, pp.79-85, 2017.

R. W. Cooke, D. Clark, M. Hickey-dwyer, and A. M. Weindling, The apparent role of blood transfusions in the development of retinopathy of prematurity, Eur J Pediatr, vol.152, pp.833-836, 1993.

S. E. Brooks, D. M. Marcus, and D. Gillis, The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study, Pediatrics, vol.104, pp.514-518, 1999.

A. Keir, S. Pal, and M. Trivella, Adverse effects of red blood cell transfusions in neonates: a systematic review and meta-analysis, Transfusion, 2016.

A. Ohlsson and S. M. Aher, Early erythropoiesis-stimulating agents in preterm or low birth weight infants, Cochrane Database Syst Rev, vol.11, p.4863, 2017.

L. W. Doyle, J. L. Cheong, R. A. Ehrenkranz, and H. L. Halliday, Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants, Cochrane Database Syst Rev, vol.10, p.1145, 2017.

L. W. Doyle, J. L. Cheong, R. A. Ehrenkranz, and H. L. Halliday, Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants, Cochrane Database Syst Rev, vol.10, p.1146, 2017.

P. Chan, S. Tang, and S. Au, Association of Gestational Hypertensive Disorders with Retinopathy of prematurity: A Systematic Review and Meta-analysis, Sci Rep, vol.6, p.30732, 2016.

S. Mitra, D. Aune, C. P. Speer, and O. D. Saugstad, Chorioamnionitis as a risk factor for retinopathy of prematurity: a systematic review and meta-analysis, Neonatology, vol.105, pp.189-199, 2014.

A. Uchida, M. Miwa, and H. Shinoda, Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks, J Ophthalmol, p.187929, 2014.

Z. Ö. Tunay, Ö. Özdemir, and D. E. Acar, Maternal Diabetes as an Independent Risk Factor for Retinopathy of Prematurity in Infants With Birth Weight of 1500 g or More, Am J Ophthalmol, vol.168, pp.201-206, 2016.

O. D. Saugstad and D. Aune, Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies, Neonatology, vol.105, pp.55-63, 2014.

L. M. Askie, B. A. Darlow, and P. G. Davis, Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants, Cochrane Database Syst Rev, vol.4, p.11190, 2017.

K. Lui, L. J. Jones, and J. P. Foster, Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth, Cochrane Database Syst Rev, vol.5, p.10239, 2018.

V. Manja, S. Lakshminrusimha, and D. J. Cook, Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis, JAMA Pediatr, vol.169, pp.332-340, 2015.

Y. Yang, Y. Feng, and X. Zhou, Inhaled nitric oxide in preterm infants: An updated meta-analysis, J Res Med Sci Off J Isfahan Univ Med Sci, vol.21, p.41, 2016.

R. L. Goldenberg, J. F. Culhane, J. D. Iams, and R. Romero, Epidemiology and causes of preterm birth, Lancet Lond Engl, vol.371, pp.75-84, 2008.

J. E. Lawn, M. G. Gravett, and T. M. Nunes, Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data, BMC Pregnancy Childbirth, vol.10, issue.1, p.1, 2010.

M. X. Repka, M. L. Hudak, C. F. Parsa, and J. M. Tielsch, Calf lung surfactant extract prophylaxis and retinopathy of prematurity, Ophthalmology, vol.99, pp.531-536, 1992.

P. M. Pennefather, W. Tin, and M. P. Clarke, Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment, Br J Ophthalmol, vol.80, pp.420-424, 1996.

S. J. Rankin, T. R. Tubman, H. L. Halliday, and S. S. Johnston, Retinopathy of prematurity in surfactant treated infants, Br J Ophthalmol, vol.76, pp.202-204, 1992.

M. X. Repka, R. J. Hardy, D. L. Phelps, and C. G. Summers, Surfactant Prophylaxis and Retinopathy of Prematurity, Arch Ophthalmol, vol.111, pp.618-620, 1993.

V. Console, L. Gagliardi, D. Giorgi, A. , D. Ponti et al., Retinopathy of prematurity and antenatal corticosteroids. The Italian ROP Study Group, Acta Bio-Medica Ateneo Parm Organo Della Soc Med E Sci Nat Parma, vol.68, issue.1, pp.75-79, 1997.

Y. Sasaki, T. Ikeda, and K. Nishimura, Association of antenatal corticosteroids and the mode of delivery with the mortality and morbidity of infants weighing less than 1,500g at birth in Japan, Neonatology, vol.106, pp.81-86, 2014.

C. Pallot, A. Soudry-faure, and C. Charvy, Screening for Retinopathy of Prematurity: Insight into Optimizing Screening, Ophthalmic Res, 2017.

F. Beby, C. Burillon, G. Putet, and P. Denis,

, J Fr Ophtalmol, vol.27, pp.337-344, 2004.

J. G. Conrath, E. J. Hadjadj, and O. Forzano, Screening for retinopathy of prematurity: results of a retrospective 3-year study of 502 infants, J Pediatr Ophthalmol Strabismus, vol.41, pp.31-34, 2004.

C. Gaugler, J. Beladdale, and D. Astruc,

, Arch Pediatr Organe Off Soc Francaise Pediatr, vol.9, pp.350-357, 2002.

A. Bonamy, J. Zeitlin, and A. Piedvache, Wide variation in severe neonatal morbidity among very preterm infants in European regions, Arch Dis Child -Fetal Neonatal Ed, pp.2017-313697, 2018.

S. Hossain, P. S. Shah, and X. Y. Ye, Outcome comparison of very preterm infants cared for in the neonatal intensive care units in Australia and New Zealand and in Canada, J Paediatr Child Health, vol.51, pp.881-888, 2015.

B. A. Darlow, M. J. Elder, and L. J. Horwood, Does observer bias contribute to variations in the rate of retinopathy of prematurity between centres?, Clin Experiment Ophthalmol, vol.36, pp.43-46, 2008.

H. Blencowe, S. Moxon, and C. Gilbert, Update on Blindness Due to Retinopathy of Prematurity Globally and in India, Indian Pediatr, vol.53, issue.2, pp.89-92, 2016.

M. Sadiq, I. Karamat, and A. A. Khan, Retinopathy of prematurity in Pakistan, J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus, vol.20, pp.541-542, 2016.

M. Gunay, G. Celik, and A. Tuten, Characteristics of Severe Retinopathy of Prematurity in Infants with Birth Weight above 1500 Grams at a Referral Center in Turkey, PloS One, vol.11, p.161692, 2016.

H. Shan, Y. Ni, and K. Xue, Type 1 Retinopathy of Prematurity and Its Laser Treatment of Large Preterm Infants in East China, PloS One, vol.10, p.144313, 2015.

A. A. Zin, M. Moreira, and C. Bunce, Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications, Pediatrics, vol.126, pp.410-417, 2010.

W. V. Good and R. J. Hardy, International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited, Arch Ophthalmol Chic Ill, vol.128, pp.991-999, 1960.

M. Nagata, Ganka, vol.10, pp.719-727, 1968.

, Contrast sensitivity at age 10 years in children who had threshold retinopathy of prematurity, Arch Ophthalmol Chic Ill, vol.119, pp.1129-1133, 1960.

V. Dobson, G. E. Quinn, and C. G. Summers, Visual acuity at 10 years in Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) study eyes: effect of retinal residua of retinopathy of prematurity, Arch Ophthalmol Chic Ill, vol.124, pp.199-202, 1960.

E. A. Palmer, Results of U.S. randomized clinical trial of cryotherapy for ROP

, Doc Ophthalmol Adv Ophthalmol, vol.74, pp.245-251, 1990.

E. A. Palmer, R. J. Hardy, and V. Dobson, 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity, Arch Ophthalmol Chic Ill, vol.123, pp.311-318, 1960.

K. Algawi, M. Goggin, and M. O&apos;keefe, Refractive outcome following diode laser versus cryotherapy for eyes with retinopathy of prematurity, Br J Ophthalmol, vol.78, pp.612-614, 1994.

D. M. Knight-nanan, O. &apos;keefe, and M. , Refractive outcome in eyes with retinopathy of prematurity treated with cryotherapy or diode laser: 3 year follow up, Br J Ophthalmol, vol.80, pp.998-1001, 1996.

B. P. Connolly, J. A. Mcnamara, and S. Sharma, A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity, Ophthalmology, vol.105, pp.1628-1631, 1998.

J. A. Mcnamara, W. Tasman, G. C. Brown, and J. L. Federman, Laser photocoagulation for stage 3+ retinopathy of prematurity, Ophthalmology, vol.98, pp.576-580, 1991.

I. A. Pearce, F. C. Pennie, and L. M. Gannon, Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser, Br J Ophthalmol, vol.82, pp.1254-1259, 1998.

B. Shalev, A. K. Farr, and M. X. Repka, Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome, Am J Ophthalmol, vol.132, pp.76-80, 2001.

A. Capone, R. Diaz-rohena, and P. Sternberg, Diode-laser photocoagulation for zone 1 threshold retinopathy of prematurity, Am J Ophthalmol, vol.116, pp.444-450, 1993.

Z. Récsán, R. Vámos, and G. Salacz, Laser treatment of zone I prethreshold and stage 3 threshold retinopathy of prematurity, J Pediatr Ophthalmol Strabismus, vol.40, pp.204-207, 2003.

B. N. Campolattaro and G. T. Lueder, Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity, Am J Ophthalmol, vol.120, pp.264-266, 1995.

H. A. Mintz-hittner and R. R. Kuffel, Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II, Retina Phila Pa, vol.28, pp.831-838, 2008.

H. A. Mintz-hittner, K. A. Kennedy, A. Z. Chuang, . Beat-rop-cooperative, and . Group, Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity, N Engl J Med, vol.364, pp.603-615, 2011.

J. Hu, M. P. Blair, and M. J. Shapiro, Reactivation of retinopathy of prematurity after bevacizumab injection, Arch Ophthalmol Chic Ill, vol.130, pp.1000-1006, 1960.

A. Travassos, S. Teixeira, and P. Ferreira, Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity, Ophthalmic Surg Lasers Imaging Off J Int Soc Imaging Eye, vol.38, pp.233-237, 2007.

Z. Li, Y. Zhang, and Y. Liao, Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP), BMC Ophthalmol, vol.18, p.19, 2018.

D. K. Vanderveen, M. Melia, and M. B. Yang, Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology, Ophthalmology, vol.124, pp.619-633, 2017.

M. J. Sankar, J. Sankar, and P. Chandra, Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity, Cochrane Database Syst Rev, vol.1, p.9734, 2018.

M. J. Sankar, J. Sankar, and P. Chandra, Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity, Cochrane Database Syst Rev, vol.1, p.9734, 2018.

L. Johnson, G. E. Quinn, and S. Abbasi, Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial, J Pediatr, vol.114, pp.827-838, 1989.

M. J. Qureshi and M. Kumar, D-Penicillamine for preventing retinopathy of prematurity in preterm infants, Cochrane Database Syst Rev, p.1073, 2013.

. Anon, Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes, Pediatrics, vol.105, pp.295-310, 2000.

S. Kaempfen, R. P. Neumann, K. Jost, and S. M. Schulzke, Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants, Cochrane Database Syst Rev, vol.3, p.11893, 2018.

L. Filippi, G. Cavallaro, and E. Berti, Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial, BMC Pediatr, vol.17, p.165, 2017.

A. Hellstrom, C. Perruzzi, and M. Ju, Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity, Proc Natl Acad Sci U S A, vol.98, pp.5804-5808, 2001.

J. Miller, E. Tonkin, and R. A. Damarell, A Systematic Review and Meta-Analysis of Human Milk Feeding and Morbidity in Very Low Birth Weight Infants, Nutrients, vol.10, 2018.

D. A. Osborn, T. Schindler, and L. J. Jones, Higher versus lower amino acid intake in parenteral nutrition for newborn infants, Cochrane Database Syst Rev, vol.3, p.5949, 2018.

A. Kychenthal and P. Dorta, Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity, Retina Phila Pa, vol.30, pp.32-36, 2010.

M. E. Hartnett, Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity, Retina Phila Pa, vol.23, pp.322-329, 2003.

B. J. Hinz, E. De-juan, and M. X. Repka, Scleral buckling surgery for active stage 4A retinopathy of prematurity, Ophthalmology, vol.105, pp.1827-1830, 1998.

M. T. Trese, Scleral buckling for retinopathy of prematurity, Ophthalmology, vol.101, pp.23-26, 1994.

M. E. Hartnett, S. Maguluri, H. W. Thompson, and J. R. Mccolm, Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity, Retina Phila Pa, vol.24, pp.753-757, 2004.

A. Capone and M. T. Trese, Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments, Ophthalmology, vol.108, pp.2068-2070, 2001.

G. B. Hubbard, D. H. Cherwick, and G. Burian, Lens-sparing vitrectomy for stage 4 retinopathy of prematurity, Ophthalmology, vol.111, pp.2274-2277, 2004.

R. Axer-siegel, I. Maharshak, and M. Snir, Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes, Retina Phila Pa, vol.28, pp.839-846, 2008.

R. R. Lakhanpal, R. L. Sun, T. A. Albini, and E. R. Holz, Anatomical success rate after primary three-port lens-sparing vitrectomy in stage 5 retinopathy of prematurity, Retina Phila Pa, vol.26, pp.724-728, 2006.

M. Cusick, M. K. Charles, and E. Agrón, Anatomical and visual results of vitreoretinal surgery for stage 5 retinopathy of prematurity, Retina Phila Pa, vol.26, pp.729-735, 2006.

H. Er, Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity, Retina Phila Pa, vol.24, pp.658-659, 2004.

J. D. Zilis, E. Machemer, and R. , Advanced retinopathy of prematurity. The anatomic and visual results of vitreous surgery, Ophthalmology, vol.97, pp.821-826, 1990.

M. E. Hartnett, M. M. Gilbert, and T. Hirose, Glaucoma as a cause of poor vision in severe retinopathy of prematurity, Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol, vol.231, pp.433-438, 1993.

T. Disher, C. Cameron, and S. Mitra, Pain-Relieving Interventions for Retinopathy of Prematurity: A Meta-analysis, Pediatrics, p.142, 2018.

A. , , 2018.

. Inserm-d, Enquête nationale périnatale Rapport 2016: les naissances et les établissements situation et évolution depuis, 2010.

G. Holmström, A. Hellström, and P. Jakobsson, Evaluation of new guidelines for ROP screening in Sweden using SWEDROP -a national quality register, Acta Ophthalmol (Copenh), vol.93, pp.265-268, 2015.

C. Löfqvist, E. Andersson, and J. Sigurdsson, Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity, Arch Ophthalmol Chic Ill, vol.124, pp.1711-1718, 1960.

C. Wu, D. K. Vanderveen, and A. Hellström, Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity, Arch Ophthalmol Chic Ill, vol.128, pp.443-447, 1960.

A. R. Wilkinson, L. Haines, and K. Head, UK retinopathy of prematurity guideline, Eye Lond Engl, vol.23, pp.2137-2139, 2009.

W. M. Fierson, American Academy of Ophthalmology, et al. Screening examination of premature infants for retinopathy of prematurity, American Academy of Pediatrics Section on Ophthalmology, vol.131, pp.189-195, 2013.

, Screening examination of premature infants for retinopathy of prematurity, American Academy of Pediatrics. Section on Ophthalmology, vol.108, pp.809-811, 2001.

A. J. Van-sorge, J. Termote, and H. J. Simonsz, Outcome and quality of screening in a nationwide survey on retinopathy of prematurity in The Netherlands, Br J Ophthalmol, vol.98, pp.1056-1060, 2014.

A. L. Jefferies, Retinopathy of prematurity: An update on screening and management, Paediatr Child Health, vol.21, pp.101-108, 2016.

C. Gilbert, R. Wormald, and A. Fielder, Potential for a paradigm change in the detection of retinopathy of prematurity requiring treatment, Arch Dis Child -Fetal Neonatal Ed, vol.101, pp.6-9, 2016.

M. I. Rothschild, R. Russ, and K. A. Brennan, The Economic Model of Retinopathy of Prematurity (EcROP) Screening and Treatment: Mexico and the United States, Am J Ophthalmol, vol.168, pp.110-121, 2016.

J. Harris, QALYfying the value of life, J Med Ethics, vol.13, pp.117-123, 1987.

J. A. Dunbar, V. Hsu, and M. Christensen, Cost-utility analysis of screening and laser treatment of retinopathy of prematurity, J Am Assoc Pediatr Ophthalmol Strabismus, vol.13, pp.186-190, 2009.

K. M. Jackson, K. E. Scott, and J. Graff-zivin, Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management, Arch Ophthalmol Chic Ill, vol.126, pp.493-499, 1960.

P. Courtright, A. K. Hutchinson, and S. Lewallen, Visual impairment in children in middleand lower-income countries, Arch Dis Child, vol.96, pp.1129-1134, 2011.

Z. Tan, C. Chong, B. Darlow, and S. Dai, Visual impairment due to retinopathy of prematurity (ROP) in New Zealand: a 22-year review, Br J Ophthalmol, vol.99, pp.801-806, 2015.

A. L. Solebo, L. Teoh, and J. Rahi, Epidemiology of blindness in children, Arch Dis Child, vol.102, pp.853-857, 2017.

U. E. Verdier-k-de, S. Löfgren, and E. Fernell, Children with blindness -major causes, developmental outcomes and implications for habilitation and educational support: a twodecade, Swedish population-based study, Acta Ophthalmol (Copenh), vol.96, pp.295-300, 2018.

A. R. O&apos;connor, C. M. Wilson, and A. R. Fielder, Ophthalmological problems associated with preterm birth, Eye Lond Engl, vol.21, pp.1254-1260, 2007.

G. E. Holmström, K. Källen, and A. Hellström, Ophthalmologic outcome at 30 months' corrected age of a prospective Swedish cohort of children born before 27 weeks of gestation: the extremely preterm infants in sweden study, JAMA Ophthalmol, vol.132, pp.182-189, 2014.

G. E. Quinn, V. Dobson, and S. Saigal, Health-related quality of life at age 10 years in very low-birth-weight children with and without threshold retinopathy of prematurity, Arch Ophthalmol Chic Ill, vol.122, pp.1659-1666, 1960.

N. S. Wood, N. Marlow, and K. Costeloe, Neurologic and developmental disability after extremely preterm birth. EPICure Study Group, N Engl J Med, vol.343, pp.378-384, 2000.

M. Hack and H. G. Taylor, Perinatal brain injury in preterm infants and later neurobehavioral function, JAMA, vol.284, pp.1973-1974, 2000.

C. S. Molloy, P. J. Anderson, V. A. Anderson, and L. W. Doyle, The long-term outcome of extremely preterm (<28 weeks' gestational age) infants with and without severe retinopathy of prematurity, J Neuropsychol, vol.10, pp.276-294, 2016.

D. Robaei, K. A. Rose, and A. Kifley, Factors associated with childhood strabismus: findings from a population-based study, Ophthalmology, vol.113, pp.1146-1153, 2006.

D. K. Vanderveen, D. L. Bremer, and R. R. Fellows, Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial, J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus, vol.15, pp.536-540, 2011.

G. Holmström and E. Larsson, Long-term follow-up of visual functions in prematurely born children--a prospective population-based study up to 10 years of age, J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus, vol.12, pp.157-162, 2008.

A. R. O&apos;connor, T. J. Stephenson, and A. Johnson, Change of refractive state and eye size in children of birth weight less than 1701 g, Br J Ophthalmol, vol.90, pp.456-460, 2006.

E. M. Harvey, V. Dobson, B. Luna, and M. S. Scher, Grating acuity and visual-field development in children with intraventricular hemorrhage, Dev Med Child Neurol, vol.39, pp.305-312, 1997.

A. R. Galiano and S. Portalier, Les fonctions du langage chez la personne aveugle. Méta-analyse de la relation entre connaissance et langage, Abstract. L'Année Psychol, vol.109, pp.123-153, 2009.
URL : https://hal.archives-ouvertes.fr/halshs-01774372

A. R. Galiano, S. Portalier, and N. Baltenneck, Étude pragmatique des compétences référentielles des personnes aveugles, Abstract. Bull Psychol, vol.518, pp.129-139, 2012.

A. P. Franz, G. U. Bolat, and H. Bolat, Attention-Deficit/Hyperactivity Disorder and Very Preterm/Very Low Birth Weight: A Meta-analysis, Pediatrics, p.141, 2018.

B. Gepner, Vers une approche interdisciplinaire, intégrative et personnalisée des troubles de la constellation autistique, Autismes et psychanalyses. ERES, vol.2014, pp.205-235

S. Portalier, Le triptyque de la déficience visuelle : affordance, vicariance et résilience, The trilogy of visual deficiency; affordance, vicariousness and resilience, Enfance, vol.2014, pp.5-17

R. P. Hobson and A. Lee, Reversible autism among congenitally blind children? A controlled follow-up study, J Child Psychol Psychiatry, vol.51, pp.1235-1241, 2010.

S. Demingeon-pessonneaux, A. Brossard, and S. Portalier, Influence du handicap dans la relation mère -enfant déficient visuel, Summary. Devenir, vol.19, pp.35-46, 2007.

G. Özyurt, A. Özyurt, and T. Ozturk, Evaluation of maternal attachment, self-efficacy, levels of depression, and anxiety in mothers who have babies diagnosed with retinopathy of prematurity, Ophthalmic Epidemiol, vol.25, pp.140-146, 2018.

J. Ryckman, C. Hilton, C. Rogers, and R. Pineda, Sensory processing disorder in preterm infants during early childhood and relationships to early neurobehavior, Early Hum Dev, vol.113, pp.18-22, 2017.

L. Hyman, Vygotsky's Crisis: Argument, context, relevance, Stud Hist Philos Biol Biomed Sci, vol.43, pp.473-482, 2012.

M. P. Pereira, Contrasting views on the pragmatic abilities of blind children, Enfance, vol.2014, pp.73-88

. Anon, Loi n° 75-534 du 30 juin 1975 d'orientation en faveur des personnes handicapées, 2018.

. Anon, Loi n° 2005-102 du 11 février 2005 pour l'égalité des droits et des chances, la participation et la citoyenneté des personnes handicapées, 2018.

N. O. Elhassan, S. Bai, and N. Gibson, The impact of prematurity and maternal socioeconomic status and education level on achievement-test scores up to 8th grade, PloS One, vol.13, p.198083, 2018.

E. E. Birch, C. S. Cheng, and J. Felius, Validity and reliability of the Children's Visual Function Questionnaire (CVFQ), J Am Assoc Pediatr Ophthalmol Strabismus, vol.11, pp.473-479, 2007.

V. Lewis, S. Norgate, and G. Collis, Les capacités de représentation d'un enfant aveugle congénital entre un et sept ans, SUMMARY Representation in a congenitally totally blind child between one and seven years, Enfance, vol.54, pp.291-307, 2002.

S. Petrou, O. Eddama, and L. Mangham, A structured review of the recent literature on the economic consequences of preterm birth, Arch Dis Child Fetal Neonatal Ed, vol.96, pp.225-232, 2011.

G. Holmström, A. Hellström, and P. Jakobsson, Evaluation of new guidelines for ROP screening in Sweden using SWEDROP -a national quality register, Acta Ophthalmol (Copenh), vol.93, pp.265-268, 2015.

G. E. Quinn, C. Barr, and D. Bremer, Changes in Course of Retinopathy of Prematurity from 1986 to 2013: Comparison of Three Studies in the United States, Ophthalmology, vol.123, pp.1595-1600, 2016.

H. S. Wong, S. Santhakumaran, and Y. Statnikov, Retinopathy of prematurity in English neonatal units: a national population-based analysis using NHS operational data, Arch Dis Child Fetal Neonatal Ed, vol.99, pp.196-202, 2014.

L. C. Bain, R. A. Dudley, J. B. Gould, and H. C. Lee, Factors associated with failure to screen newborns for retinopathy of prematurity, J Pediatr, vol.161, pp.819-823, 2012.

M. X. Repka, B. Tung, and W. V. Good, Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity Study (ETROP), Arch Ophthalmol Chic Ill, vol.124, pp.24-30, 1960.

W. V. Good, Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial, Trans Am Ophthalmol Soc, vol.102, pp.233-248, 2004.

S. Vandentorren, C. Bois, and C. Pirus, Rationales, design and recruitment for the Elfe longitudinal study, BMC Pediatr, vol.9, p.58, 2009.

A. Ego, C. Prunet, and B. Blondel, Customized and non-customized French intrauterine growth curves. II -Comparison with existing curves and benefits of customization, J Gynecol Obstet Biol Reprod, pp.165-76, 2016.

P. Delorme, F. Goffinet, and P. Ancel, Cause of Preterm Birth as a Prognostic Factor for Mortality, Obstet Gynecol, vol.127, pp.40-48, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02007832

J. J. Volpe, Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances, Lancet Neurol, vol.8, pp.110-124, 2009.

A. H. Jobe, E. Bancalari, and . Bronchopulmonary, Am J Respir Crit Care Med, vol.163, pp.1723-1729, 2001.

M. J. Bell, J. L. Ternberg, and R. D. Feigin, Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging, Ann Surg, vol.187, pp.1-7, 1978.

. Anon and . Haute, Autorité de Santé -Diagnostic et traitement curatif de l'infection bactérienne précoce du nouveau-né, 2018.

B. J. Stoll, N. Hansen, and A. A. Fanaroff, Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network, Pediatrics, vol.110, pp.285-291, 2002.

B. Larroque, G. Bréart, and M. Kaminski, Survival of very preterm infants: Epipage, a population based cohort study, Arch Dis Child Fetal Neonatal Ed, vol.89, pp.139-144, 2004.

D. J. Evans and M. I. Levene, Evidence of selection bias in preterm survival studies: a systematic review, Arch Dis Child Fetal Neonatal Ed, vol.84, pp.79-84, 2001.

A. J. Van-sorge, J. Termote, and H. J. Simonsz, Outcome and quality of screening in a nationwide survey on retinopathy of prematurity in The Netherlands, Br J Ophthalmol, vol.98, pp.1056-1060, 2014.

N. G. Ziakas, D. G. Cottrell, and D. W. Milligan, Regionalisation of retinopathy of prematurity (ROP) screening improves compliance with guidelines: an audit of ROP screening in the Northern Region of England, Br J Ophthalmol, vol.85, pp.807-810, 2001.

B. Bolt, B. Benz, F. Koerner, and E. Bossi, A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study, J Pediatr Ophthalmol Strabismus, vol.29, pp.157-162, 1992.

A. L. Ells, J. M. Holmes, and W. F. Astle, Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study, Ophthalmology, vol.110, pp.2113-2117, 2003.

S. K. Wang, N. F. Callaway, and M. B. Wallenstein, SUNDROP: six years of screening for retinopathy of prematurity with telemedicine, Can J Ophthalmol J Can Ophtalmol, vol.50, pp.101-106, 2015.

A. N. Mukherjee, P. Watts, and H. Al-madfai, Impact of retinopathy of prematurity screening examination on cardiorespiratory indices: a comparison of indirect ophthalmoscopy and retcam imaging, Ophthalmology, vol.113, pp.1547-1552, 2006.

J. Lee, Y. E. Du, and O. Coki, Parental perceptions toward digital imaging and telemedicine for retinopathy of prematurity management, Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol, vol.248, pp.141-147, 2010.

M. F. Chiang, J. D. Keenan, and J. Starren, Accuracy and reliability of remote retinopathy of prematurity diagnosis, Arch Ophthalmol Chic Ill, vol.124, pp.322-327, 1960.

B. Blondel, B. Coulm, and C. Bonnet, Trends in perinatal health in metropolitan France from 1995 to 2016: Results from the French National Perinatal Surveys, J Gynecol Obstet Hum Reprod, vol.46, pp.701-713, 2017.

. Inserm-d, Enquete Nationale Perinatale Rapport 2016: les naissances et les établissements situation et évolution depuis 2010, 2017.

C. Prunet, F. Goffinet, and B. Blondel, Medical care and perinatal health in twin pregnancies: situation in 2010 and recent trends in France

, J Gynecol Obstet Biol Reprod, vol.44, pp.184-193, 2015.

, Serment d'Hippocrate

, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité. Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences. Je donnerai mes soins à l'indigent et à quiconque me les demandera, J'informerai les patients des décisions envisagées, de leurs raisons et de leurs conséquences

, Admis(e) dans l'intimité des personnes, je tairai les secrets qui me seront confiés

, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

F. Titre-en and . Prematures,

. Résumé, ROP) est une maladie cécitante nécessitant un dépistage dont l'observance est rarement évaluée. L'objectif était de déterminer la prévalence de l'examen du fond d'oeil (FO) chez les prématurés nés avant 32 SA ainsi que les facteurs enfants et centres associés au dépistage de la ROP en France. Pour ce faire, les données issues d'EPIPAGE-2, une cohorte observationnelle de prématurés nés en France en, La rétinopathie du prématuré, 2011.

. Au-total, Les caractéristiques infantiles associées à l'examen du FO étaient un faible âge gestationnel, un faible poids à la naissance, une dysplasie bronchopulmonaire sévère, des lésions neurologiques graves et un transfert vers une autre unité au moment du dépistage. La probabilité de dépistage était augmentée chez les nourrissons hospitalisés dans des unités utilisant l'imagerie grand angle, 5%) des enfants éligibles au dépistage ont subi un examen du FO (de 96% à 24 SA à 50% à 31 SA), p.65

, Avoir été dépisté à temps était associé à un âge gestationnel élevé et à l'utilisation de l'imagerie grand angle

, Pour conclure, les enfants les plus à risque de ROP étaient les mieux dépistés, mais souvent avec un retard. La meilleure compliance des unités néonatales utilisant l'imagerie grand champ plaide pour sa diffusion Mots clés (français) : Rétinopathie des prématurés, dépistage

. Abstract, Children born before 32 WG without severe malformation alive at the recommended time for ROP screening were included and analyzed using mixed model. In total, 2169/3077 (70.5%) of the children eligible for screening underwent a fundus examination (from 96% at 24 WG to 50% at 31 WG). The infant characteristics associated with fundus examination were small gestational age, low birth weight, severe bronchopulmonary dysplasia, severe neurological lesions and a transfer to another neonatal unit at the recommended screening schedule. Odd of screening was increased for infants hospitalized in units using wide-angle imaging, Retinopathy of prematurity (ROP) is a severe blinding disease requiring screening which compliance is rarely evaluated. The objective was to determine the prevalence of fundus examination in infants born very preterm and the individual-and center-related factors associated with ROP screening in France